Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities:      
Consolidated net income $ 664.3 $ 607.3 $ 551.7
Adjustments to reconcile consolidated net income to net cash provided by operating activities:      
Depreciation and amortization 726.9 680.6 619.8
Stock-based compensation expense 78.4 81.6 71.8
Deferred income taxes 30.2 (66.9) (70.2)
Gain on fair market value adjustment and gain on sale of equity investments (1.2) 0.0 (13.8)
Changes in assets and liabilities, excluding effects of acquisitions:      
Accounts receivable, net (40.9) (66.3) (23.3)
Other assets, current and long-term 42.6 (29.5) (13.0)
Current and long-term liabilities, excluding debt 115.4 117.7 (6.2)
Cash provided by operating activities 1,615.7 1,324.5 1,116.8
Investing activities:      
Capital expenditures (481.4) (511.5) (601.3)
Acquisitions, net of cash acquired (74.1) 0.0 (283.8)
Cash received from divestitures 1.2 0.0 6.9
Cash used in investing activities (554.3) (511.5) (878.2)
Financing activities:      
Net short-term borrowings (payments) 474.7 91.2 (371.2)
Payments on long-term debt (400.2) (1,445.6) (579.3)
Proceeds from issuance of long-term debt 1.7 649.8 872.9
Treasury stock purchases (927.5) 0.0 0.0
Dividends paid to Equifax shareholders (232.8) (193.2) (191.8)
Distributions paid to noncontrolling interests (6.1) (4.6) (45.6)
Proceeds from exercise of stock options and employee stock purchase plan 46.4 78.2 32.3
Payment of taxes related to settlement of equity awards (15.0) (16.8) (17.3)
Purchase of redeemable noncontrolling interests (0.9) 0.0 0.0
Debt issuance costs 0.0 (5.4) (6.2)
Cash used in financing activities (1,059.7) (846.4) (306.2)
Effect of foreign currency exchange rates on cash and cash equivalents 9.2 (13.5) (0.8)
Increase (decrease) in cash and cash equivalents 10.9 (46.9) (68.4)
Cash and cash equivalents, beginning of period 169.9 216.8 285.2
Cash and cash equivalents, end of period $ 180.8 $ 169.9 $ 216.8